药学学报, 2020, 55(12): 2942-2950
引用本文:
马林, 邵明燕, 孙乾斌, 李春, 王勇. 基于网络药理学的丹七片治疗冠心病作用机制研究[J]. 药学学报, 2020, 55(12): 2942-2950.
MA Lin, SHAO Ming-yan, SUN Qian-bin, LI Chun, WANG Yong. The mechanism of Danqi tablets in the treatment of coronary heart disease based on network pharmacology[J]. Acta Pharmaceutica Sinica, 2020, 55(12): 2942-2950.

基于网络药理学的丹七片治疗冠心病作用机制研究
马林1, 邵明燕1, 孙乾斌1, 李春2, 王勇3
1. 北京中医药大学生命科学学院, 北京 100029;
2. 北京中医药大学中药学院, 北京 100029;
3. 北京中医药大学中医学院, 北京 100029
摘要:
利用网络药理学方法探究丹七片治疗冠心病的活性成分和作用机制,为临床冠心病的治疗提供理论依据。采用TCMSP数据库筛选出丹七片的活性成分及其靶标;通过GeneCards数据库筛选冠心病的预测靶点;将两者靶点进行映射交集;利用STRING数据库构建蛋白互作网络图并筛选出65个核心靶点;再通过DAVID数据库进行GO(gene ontology)生物过程和KEGG信号通路富集分析,最后利用Cytoscape-3.6.2软件构建活性成分-关键靶点-作用通路网络图。通过建立过氧化氢(H2O2)诱导的心肌细胞H9C2损伤模型,对关键活性成分进行实验验证。网络药理学研究提示,丹七片通过槲皮素、木犀草素和丹参酮ⅡA等活性成分作用于炎症因子和细胞凋亡相关通路,改善体内促炎或抗炎失衡,保护心肌细胞,从而达到治疗冠心病的目的,证实了丹七片治疗冠心病多成分、多靶点的作用特点,为其进一步的实验研究及临床诊治提供客观依据。
关键词:    网络药理学      丹七片      冠心病      作用机制      靶点     
The mechanism of Danqi tablets in the treatment of coronary heart disease based on network pharmacology
MA Lin1, SHAO Ming-yan1, SUN Qian-bin1, LI Chun2, WANG Yong3
1. School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China;
2. School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China;
3. School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
Abstract:
We used the network pharmacology to explore the active ingredients and mechanism of action of Danqi tablets in the treatment of coronary heart disease, providing a theoretical basis for the treatment of clinical coronary heart disease. The TCMSP database was used to screen for active ingredients and targets in Danqi tablets; the predicted targets of coronary heart disease were screened through the GeneCards database; then, the intersection of the two targets was mapped; we used STRING database to construct a protein interaction network map and identified 65 cores targets; then, the DAVID database was used for enrichment analysis of gene ontology (GO) biological processes and KEGG signaling pathways, and finally the Cytoscape-3.6.2 software was used to construct a network diagram of traditional Chinese medicine-active ingredient-key targets-pathway. The H2O2-induced H9C2 cells injury model was used for experimental verification. The results suggest that Danqi tablets act on inflammatory factors and apoptosis-related pathways through quercetin, luteolin, tanshinone ⅡA, and other active ingredients, and improve proinflammatory or anti-inflammatory imbalances in the body and protect cardiomyocytes. This study confirms the multi-component and multi-target effects of Danqi tablets in the treatment of coronary heart disease, and provides an objective basis for their use in further experimental research and the clinical diagnosis and treatment of coronary heart disease.
Key words:    network pharmacology    Danqi tablet    coronary heart disease    mechanism    target   
收稿日期: 2020-05-17
DOI: 10.16438/j.0513-4870.2020-0761
基金项目: 国家自然科学基金资助项目(81822049,81673712).
通讯作者: 王勇,Tel:86-10-64286491,E-mail:doctor_wangyong@163.com
Email: doctor_wangyong@163.com
相关功能
PDF(1449KB) Free
打印本文
0
作者相关文章
马林  在本刊中的所有文章
邵明燕  在本刊中的所有文章
孙乾斌  在本刊中的所有文章
李春  在本刊中的所有文章
王勇  在本刊中的所有文章

参考文献:
[1] World Health Organization. World Health Statistics 2017:Monitoring Health for the SDGs[R]. Geneva:World Health Organization, 2017:47.
[2] Wang J, Chen KJ. On the concept and scope of blood stagnation[J]. Acta Med Sin (中国医药学报), 1989, 4:7-9.
[3] Gong DK, Zhang XM. Clinical observation of Danqi pill in the treatment of coronary heart disease[J]. Chin J Ethnomed Ethnopharm (中国民族民间医药), 2009, 18:125.
[4] Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (中华人民共和国药典)[S]. Beijing:China Medical Science Press, 2010:107-116.
[5] Guo SZ, Wang Y, Chuo WJ, et al. Effect of Danqi tablet on myocardial structure and function of chronic myocardial ischemia swines[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2014, 32:1889-1891.
[6] Hopkins AL. Network pharmacology[J]. Nat Biotechnol, 2007, 25:1110-1111.
[7] Ru J, Li P, Wang J, et al. TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6:13.
[8] The UniProt Consortium. UniProt:the universal protein knowledgebase[J]. Nucleic Acids Res, 2018, 46:2699.
[9] Yao YX, He ZX, Liu XF, et al. Potential material basis of Kangbingdu Granules for treatment of coronavirus disease 2019(COVID-19) based on network pharmacology and molecular docking technology[J]. Chin Tradit Herb Drugs (中草药), 2020, 51:1386-1396.
[10] Dai JR, Wei WF, Huo JH, et al. Research progress of network pharmacology in traditional Chinese medicine[J]. Heilongjiang J Tradit Chin Med (黑龙江中医药), 2018, 47:105-107.
[11] Guo TT, Zhou D, Dang W, et al. Study on anti-Alzheimer's disease mechanism of sesquiterpene coumarins based on network pharmacology[J]. J Shenyang Pharm Univ (沈阳药科大学学报), 2020, 37:69-76.
[12] Li C, Hu Q, Zhang YX, et al. Research progress on pharmacological activity of quercetin[J]. Hubei J Tradit Chin Med (湖北中医杂志), 2018, 40:63-66.
[13] Sun J, Wen CM, Zhang BC, et al. The protective effect of quercetin on vascular endothelial progenitor cells by regulating PI3K/Akt signaling pathway and its mechanisms[J]. Chin Pharmacol Bull (中国药理学通报), 2019, 35:85-90.
[14] Deng DY. Effects of Luteolin on A 549 Cells Infected with Influenza H1N1 Virus and Its Immunoregulatory Mechanism木犀草素对流感病毒H1N1感染A549细胞的作用及免疫调节机制的研究)[D]. Beijing:Beijing University of Chinese Medicine, 2017.
[15] Chang H, Li C, Huo K, et al. Luteolin prevents H2O2-induced apoptosis in H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway[J]. Biomed Res Int, 2016, 2016:5125836.
[16] Wang X, Li C, Wang Q, et al. Tanshinone ⅡA restores dynamic balance of autophagosome/autolysosome in doxorubicin-induced cardiotoxicity via targeting Beclin1/LAMP1[J]. Cancers (Basel), 2019, 11:910.
[17] Zhang X, Wang Q, Wang X, et al. Tanshinone ⅡA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway[J]. Biomed Pharmacother, 2019, 112:108599.
[18] Wang X, Wang F. Advances in the study of plant sterols[J]. Foreign Med Sci (Hyg) (国外医学(卫生学分册)), 2007, 34:98-101.
[19] Zen J, Zhang ZR, Miao P, et al. Advances in pharmacological action of cryptotanshinone[J]. Chin Tradit Pat Med (中成药), 2015, 37:1309-1313.
[20] Wu WY, Yang Z, Long FX, et al. The regulation of costunolide on colorectal cancer cell proliferation, apoptosis, invasion and migration through PI3K/AKT signaling pathway[J]. J Chin Med Mater (中药材), 2020, 43:429-435.
[21] Li B, Yang M, Liu JW, et al. Protective mechanism of quercetin on acute myocardial infarction in rats[J]. Genet Mol Res, 2016, 15:15017117.
[22] Zhang JF, Ma YT, Yang YN, et al. Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts[J]. Chin J Cardiol (中华心血管病杂志), 2008, 36:161-166.
[23] Schülke S. Induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses[J]. Front Immunol, 2018, 9:455.
[24] Strobl J, Pandey RV, Kausgruber T, et al. Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease[J]. J Invest Dermatol, 2020.DOI:10.1016/j.jid.2020.02.029.
[25] Jiao S, Tang B, Wang Y, et al. Pro-angiogenic role of Danqi pill through activating fatty Acids oxidation pathway against coronary artery disease[J]. Front Pharmacol, 2018, 9:1414.
[26] Zhang Q, Shao M, Zhang X, et al. The effect of Chinese medicine on lipid and glucose metabolism in acute myocardial infarction through PPARγ pathway[J]. Front Pharmacol, 2018, 9:1209.
[27] Jiang H, Abel PW, Toews ML, et al. Phosphoinositide 3-kinase gamma regulates airway smooth muscle contraction by modulating calcium oscillations[J]. J Pharmacol Exp Ther, 2010, 334:703-709.
[28] Ambrose LJ, Abd-Jamil AH, Gomes RS, et al. Investigating mitochondrial metabolism in contracting HL-1 cardiomyocytes following hypoxia and pharmacological HIF activation identifies HIF-dependent and independent mechanisms of regulation[J]. J Cardiovasc Pharmacol Ther, 2014, 19:574-585.
[29] Li Z, Hou J, Deng Y, et al. Exploring the protective effects of Danqi Tongmai tablet on acute myocardial ischemia rats by comprehensive metabolomics profiling[J]. Phytomedicine, 2020, 74:152918.
[30] Zheng S, Zhang Y, Qiao Y. Network analysis of primary active compounds in Danqi analogous formulas for treating cardiovascular disease[J]. J Tradit Chin Med Sci, 2016, 3:116-123.
相关文献:
1.黄友, 杨莎莎, 林夏, 赵生嘉, 魏馨怡, 傅超美, 张臻.基于网络药理-分子对接研究附子理中丸治疗溃疡性结肠炎的作用机制[J]. 药学学报, 2020,55(8): 1812-1822
2.钟仁兴, 丁子禾, 杨燕妮, 夏天乙, 王武静, 王毅, 王艳慧, 舒尊鹏.基于网络药理学分析的橘红痰咳液主治“痰、咳、喘”的药效物质基础与作用机制研究[J]. 药学学报, 2020,55(9): 2134-2144
3.宋红新, 马旭冉, 王敦方, 王彦礼, 邹迪新, 苗金雪, 王汉, 杨伟鹏.基于网络药理学的黄芩汤治疗溃疡性结肠炎的潜在机制研究[J]. 药学学报, 2020,55(2): 247-255
4.郑一夫, 孔令雷, 贾皓, 张宝月, 王喆, 许律捷, 刘艾林, 杜冠华.基于系统的化合物-靶点相互作用预测模型的消栓通络方抗脑卒中网络药理学研究[J]. 药学学报, 2020,55(2): 256-264
5.高凤凤, 裴艳玲, 任越, 陈紫军, 卢建秋, 张燕玲.基于网络药理学与分子对接技术研究黄精抗动脉粥样硬化的作用机制[J]. 药学学报, 2020,55(11): 2642-2650
6.田瑞, 李宇飞, 李莹倩, 郑继雯, 李华山.基于网络药理学探讨李氏溃结方治疗溃疡性结肠炎的分子机制[J]. 药学学报, 2020,55(11): 2657-2664
7.董雅倩, 张佳幸, 龚琳娜, 石碧锐, 周凤华, 肖炜, 刘孟华.白花蛇舌草环烯醚萜的鉴定及基于网络药理学的抗肾纤维化作用的机制研究[J]. 药学学报, 2020,55(12): 2934-2941
8.袁文彬, 韦艳美, 陈勇, 梁继超.基于网络药理学对刺五加总苷治疗2型糖尿病作用机制研究[J]. 药学学报, 2019,54(11): 1982-1989
9.史海龙, 冯雪松, 马晓军, 胥冰, 晁旭.基于网络药理学的固肠止泻丸治疗肠易激综合征作用机制研究[J]. 药学学报, 2019,54(3): 482-493
10.郭秋岩, 李玮婕, 王超, 曹人郦, 李泰贤, 毛霞, 王晓月, 郭敏群, 张彦琼, 林娜.乌头汤缓解神经病理性疼痛的炎症网络调控机制研究[J]. 药学学报, 2019,54(6): 1054-1061
11.沈霞, 任丹, 高静, 张岗, 王永华, 彭亮, 裴丽珊.基于网络药理学复方龙脉宁方治疗脑卒中的分子机制研究[J]. 药学学报, 2019,54(9): 1588-1596
12.李玉斌, 吕超, 张卫东.非标记的天然产物靶点识别和确证方法及应用[J]. 药学学报, 2019,54(1): 82-88
13.张莹, 韦佳慧, 张成玲, 李攀红, 孙文威, 徐晓玉, 陈怡.基于网络药理学的加味佛手散抑制子宫内膜侵袭转移机制研究[J]. 药学学报, 2018,53(9): 1398-1405
14.宋勇丽, 王政霖, 邢玮, 吴晏, 王伟, 韩静.基于网络药理学的复方血栓通治疗糖尿病视网膜病的药理机制研究[J]. 药学学报, 2018,53(9): 1442-1448
15.时悦, 姚璎珈, 蔺莹, 梁喜才, 倪颖男, 吴雨桐, 杨静娴.基于网络药理学的开心散治疗阿尔茨海默病的作用机制分析[J]. 药学学报, 2018,53(9): 1458-1466
16.李建良, 梁慧, 蔡淑珍, 李志勇, 图雅.基于网络药理学探讨蒙药诃子解草乌心脏毒的机制研究[J]. 药学学报, 2018,53(10): 1670-1679
17.吴丹, 高耀, 向欢, 邢婕, 韩雨梅, 秦雪梅, 田俊生.基于网络药理学的柴胡抗抑郁作用机制研究[J]. 药学学报, 2018,53(2): 210-219
18.翟园园, 刘其南, 徐佳, 姚卫峰, 包贝华, 曹雨诞, 张丽, 丁安伟.基于网络药理学的二至丸保肝作用机制研究[J]. 药学学报, 2018,53(4): 567-573
19.王珂欣, 高丽, 周玉枝, 张建琴, 秦雪梅, 杜冠华.基于网络药理学的苦参碱抗肝癌作用及机制研究[J]. 药学学报, 2017,52(6): 888-896
20.赵蕾, 武嫣斐, 高耀, 向欢, 秦雪梅, 田俊生.基于网络药理学的百合地黄汤干预心理亚健康作用机制研究[J]. 药学学报, 2017,52(1): 99-105
21.孙莉敏, 刘丽芳, 朱华旭, 朱宝杰, 张启春.基于网络药理学的黄连解毒汤治疗阿尔兹海默症的作用机制研究[J]. 药学学报, 2017,52(8): 1268-1275
22.陶瑾, 姜民, 陈露莹, 侯媛媛, 张德芹, 邱峰, 白钢.基于中药性味理论和网络药理学方法的治疗消渴方药作用机制研究[J]. 药学学报, 2017,52(2): 236-244
23.许律捷, 姜雯, 庞晓丛, 康德, 熊婉迪, 刘睿, 邢建国, 刘艾林, 杜冠华.复方一枝蒿抗流感有效成分的网络药理学研究[J]. 药学学报, 2017,52(5): 745-752
24.牟海栋, 屠鹏飞, 姜勇.基于网络药理学的肉桂温经通脉的作用机制研究[J]. 药学学报, 2016,51(11): 1724-1733
25.韩彦琪, 许浚, 张喜民, 张铁军, 任一杰, 刘昌孝.基于网络药理学的元胡止痛滴丸治疗原发性痛经的作用机制研究[J]. 药学学报, 2016,51(3): 380-387
26.陈建丽, 高耀, 秦雪梅, 田俊生.基于网络药理学的复方柴归方超临界CO2萃取组分的抗抑郁作用机制[J]. 药学学报, 2016,51(3): 388-395
27.高耀, 高丽, 高晓霞, 周玉枝, 秦雪梅, 田俊生.基于网络药理学的逍遥散抗抑郁活性成分作用靶点研究[J]. 药学学报, 2015,50(12): 1589-1595
28.白雨, 范雪梅, 孙瀚, 王义明, 梁琼麟, 罗国安.基于网络药理学的罗格列酮复方作用机制探讨[J]. 药学学报, 2015,50(3): 284-290